Tudor Investment Corp’s PRA Health Sciences, Inc. PRAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-111,385
Closed -$18.4M 2984
2021
Q2
$18.4M Buy
111,385
+4,081
+4% +$681K 0.35% 35
2021
Q1
$16.5M Buy
+107,304
New +$14.6M 0.33% 41
2020
Q2
Sell
-4,065
Closed -$338K 1514
2020
Q1
$338K Sell
4,065
-9,585
-70% -$935K 0.03% 643
2019
Q4
$1.52M Sell
13,650
-898
-6% -$92.4K 0.07% 385
2019
Q3
$1.44M Buy
14,548
+7,354
+102% +$730K 0.05% 396
2019
Q2
$713K Buy
+7,194
New +$687K 0.02% 598
2017
Q4
Sell
-8,397
Closed -$640K 1359
2017
Q3
$640K Sell
8,397
-6,070
-42% -$459K 0.02% 560
2017
Q2
$1.08M Buy
14,467
+4,056
+39% +$281K 0.03% 318
2017
Q1
$679K Sell
10,411
-19,309
-65% -$1.14M 0.02% 541
2016
Q4
$1.64M Sell
29,720
-5,773
-16% -$317K 0.04% 217
2016
Q3
$2.01M Sell
35,493
-8,437
-19% -$414K 0.05% 210
2016
Q2
$1.83M Buy
43,930
+7,229
+20% +$333K 0.04% 245
2016
Q1
$1.57M Buy
36,701
+15,454
+73% +$653K 0.04% 336
2015
Q4
$962K Buy
21,247
+401
+2% +$16.8K 0.03% 477
2015
Q3
$809K Buy
20,846
+12,705
+156% +$509K 0.03% 488
2015
Q2
$296K Buy
+8,141
New +$258K 0.01% 1113

Other funds holding PRAH

Tudor Investment Corp's PRAH Position: Q3 2021 in Review

Tudor Investment Corp sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 111,385 shares — an estimated $18.4M sold.

Tudor Investment Corp first reported a position in PRAH in Q2 2015 and held it in 16 quarters. The position peaked at $18.4M in Q2 2021. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.

  • Tudor Investment Corp reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
  • Tudor Investment Corp sold 111,385 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $18.4M.
  • Tudor Investment Corp first reported a position in PRA Health Sciences, Inc. in Q2 2015 and held it in 16 quarters.
  • Tudor Investment Corp's PRA Health Sciences, Inc. position peaked at $18.4M in Q2 2021.
  • 1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.

Based on Tudor Investment Corp's 13F filing for Q3 2021, filed 15 Nov 2021.